• Ionis Pharmaceuticals EPS for the quarter ending September 30, 2024 was $-0.95, a 7.77% decline year-over-year.
• Ionis Pharmaceuticals 2023 annual EPS was $-2.56, a 34.74% increase from 2022.
• Ionis Pharmaceuticals 2022 annual EPS was $-1.9, a 850% increase from 2021.
• Ionis Pharmaceuticals 2021 annual EPS was $-0.2, a 93.71% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.